These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19176684)

  • 1. The effect of rabbit anti-thymocyte globulin induction therapy on regulatory T cells in kidney transplant patients.
    Sewgobind VD; Kho MM; van der Laan LJ; Hendrikx TK; van Dam T; Tilanus HW; IJzermans JN; Weimar W; Baan CC
    Nephrol Dial Transplant; 2009 May; 24(5):1635-44. PubMed ID: 19176684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The calcineurin inhibitor tacrolimus allows the induction of functional CD4CD25 regulatory T cells by rabbit anti-thymocyte globulins.
    Sewgobind VD; van der Laan LJ; Kho MM; Kraaijeveld R; Korevaar SS; Mol W; Weimar W; Baan CC
    Clin Exp Immunol; 2010 Aug; 161(2):364-77. PubMed ID: 20528886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical rejection and persistent immune regulation in kidney transplant patients.
    Hendrikx TK; Klepper M; Ijzermans J; Weimar W; Baan CC
    Transpl Immunol; 2009 Jul; 21(3):129-35. PubMed ID: 19398001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T cells in kidney transplant recipients: the effect of induction immunosuppression therapy.
    Krystufkova E; Sekerkova A; Striz I; Brabcova I; Girmanova E; Viklicky O
    Nephrol Dial Transplant; 2012 Jun; 27(6):2576-82. PubMed ID: 22167587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
    Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
    Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of rabbit antithymocyte globulins-induced CD25+ regulatory T cells from cells of patients with end-stage renal disease.
    Sewgobind VD; van der Laan LJ; Kho MM; Kraaijeveld R; Korevaar SS; van Dam T; Ijzermans JN; Weimar W; Baan CC
    Transplantation; 2010 Mar; 89(6):655-66. PubMed ID: 20164820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of suppressive allogeneic regulatory T cells via rabbit antithymocyte polyclonal globulin during homeostatic proliferation in rat kidney transplantation.
    Valdez-Ortiz R; Bestard O; Llaudó I; Franquesa M; Cerezo G; Torras J; Herrero-Fresneda I; Correa-Rotter R; Grinyó JM
    Transpl Int; 2015 Jan; 28(1):108-19. PubMed ID: 25208307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy.
    Kamburova EG; Koenen HJ; van den Hoogen MW; Baas MC; Joosten I; Hilbrands LB
    PLoS One; 2014; 9(11):e112658. PubMed ID: 25393622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of bona fide regulatory T cells after liver transplantation - the potential influence of polyclonal antithymocyte globulin.
    Stauch D; Yahyazadeh A; Bova R; Melloh GC; Füldner A; Baron U; Olek S; Göldner K; Weiss S; Pratschke J; Kotsch K
    Transpl Int; 2012 Mar; 25(3):302-13. PubMed ID: 22188119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different immunosuppressive combinations on T-cell regulation in renal transplant recipients.
    Fourtounas C; Dousdampanis P; Sakellaraki P; Rodi M; Georgakopoulos T; Vlachojannis JG; Mouzaki A
    Am J Nephrol; 2010; 32(1):1-9. PubMed ID: 20484893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of induction therapy on the expression of molecular markers associated with rejection and tolerance.
    Krepsova E; Tycova I; Sekerkova A; Wohlfahrt P; Hruba P; Striz I; Sawitzki B; Viklicky O
    BMC Nephrol; 2015 Aug; 16():146. PubMed ID: 26286066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD127(low) expression in CD4+CD25(high) T cells as immune biomarker of renal function in transplant patients.
    Alonso-Arias R; Suárez-Alvarez B; López-Vázquez A; Moro MA; Baltar J; Gómez-Huertas E; Ortega T; Ortega F; López-Larrea C
    Transplantation; 2009 Aug; 88(3 Suppl):S85-93. PubMed ID: 19667968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of CD4+ CD25bright T cells in kidney transplant patients: improving suppression of donor-directed responses after transplantation.
    Sewgobind VD; van der Laan LJ; Klepper M; Ijzermans JN; Tilanus HW; Weimar W; Baan CC
    Clin Transplant; 2008; 22(5):579-86. PubMed ID: 18435785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T-cells in Graves' orbitopathy: baseline findings and immunomodulation by anti-T lymphocyte globulin.
    Kahaly GJ; Shimony O; Gellman YN; Lytton SD; Eshkar-Sebban L; Rosenblum N; Refaeli E; Kassem S; Ilany J; Naor D
    J Clin Endocrinol Metab; 2011 Feb; 96(2):422-9. PubMed ID: 21147887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+CD25+Foxp3+IFN-γ+ human induced T regulatory cells are induced by interferon-γ and suppress alloresponses nonspecifically.
    Daniel V; Sadeghi M; Wang H; Opelz G
    Hum Immunol; 2011 Sep; 72(9):699-707. PubMed ID: 21664396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monotherapy rapamycin allows an increase of CD4 CD25 FoxP3 T cells in renal recipients.
    Hendrikx TK; Velthuis JH; Klepper M; van Gurp E; Geel A; Schoordijk W; Baan CC; Weimar W
    Transpl Int; 2009 Sep; 22(9):884-91. PubMed ID: 19453998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of high anti-donor alloreactivity and low frequency of FoxP3-expressing cells prior to kidney transplantation with acute graft rejection.
    Vondran FW; Timrott K; Tross J; Kollrich S; Gwinner W; Lehner F; Klempnauer J; Becker T; Schwinzer R
    Clin Transplant; 2011; 25(6):905-14. PubMed ID: 21070367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of CD127 combined with FOXP3 for identification of operational tolerance after liver transplantation.
    Nafady-Hego H; Li Y; Ohe H; Elgendy H; Zhao X; Sakaguchi S; Bishop GA; Koshiba T
    Transpl Immunol; 2016 May; 36():1-8. PubMed ID: 27105585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a Weight-based Rabbit Anti-thymocyte Globulin Induction Dosing Regimen for Kidney Transplant Recipients.
    Pennington CA; Tischer SM; Lee E; Lee S; Sindelar J; Park JM
    Pharmacotherapy; 2015 Aug; 35(8):748-54. PubMed ID: 26234282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regulatory T cells in kidney transplant recipients].
    Libetta C; Portalupi V; Margiotta E; Sepe V; Canevari M; Meloni F; Morosini M; Dal Canton A
    G Ital Nefrol; 2009; 26 Suppl 45():S54-7. PubMed ID: 19382095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.